| Name |
histone deacetylase 6 |
farnesyltransferase, CAAX box, subunit beta |
| Structure |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
- AZD3409
- Tipifarnib
- Lonafarnib
- 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE
- (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE
- L-778123
- [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID
- Farnesyl diphosphate
- Geranylgeranyl diphosphate
- ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
- (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE
- (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE
|
| GWAS |
No GWAS studies recorded
|
|
| Interacting Genes |
83 interacting genes:
ADRB2
APOBEC3G
ARHGDIA
ATF3
BBS10
BCL3
BCOR
BRMS1
CDKN1A
CEP70
CRBN
CSNK2A2
CYLD
DSCR9
DYNLL2
EP300
ERBB2
ERBB3
ERBB4
FBP1
FBXO11
FNTA
FNTB
GRK2
H2AX
H4C16
HDAC11
HES1
HTATIP2
HTATSF1
ISG15
JDP2
KPNA1
LCOR
LINC00624
LPXN
MAPK1
MAPK3
MAPT
MLH1
MOB1A
MSH2
NACAD
NASP
NEDD8
NR0B2
NR3C1
PLAA
POLA2
POLDIP2
POLR1B
PPP1CC
PRDX4
PRKCZ
PRKN
PROM1
PTOV1
PXN
RELB
RNF168
RNF31
RUNX2
SEPTIN7
SIRT2
SYK
TEKT4
TPPP
TRIM50
TUBA1B
TUBA4A
TUBB
TUBB2B
UBB
UBC
UBE2D1
UBE2D3
UBE2E1
UBE2H
USP10
VCP
VKORC1
ZBTB16
ZNF205
|
17 interacting genes:
AGXT
APOL6
ATPAF2
CCDC24
CENPF
FNTA
GBP1
HDAC6
HOXC8
HRAS
KRABD3
KRAS
PTP4A3
RAP2A
RRAS2
SMG9
TLX3
|
| Entrez ID |
10013 |
2342 |
| HPRD ID |
02228
|
00608
|
| Ensembl ID |
ENSG00000094631
|
ENSG00000257365
|
| Uniprot IDs |
B4DZH6
Q9BRX7
Q9UBN7
|
A0A384MEJ5
P49356
|
| PDB IDs |
3C5K
3GV4
3PHD
5B8D
5EDU
5KH3
5KH7
5KH9
5WBN
5WPB
6CE6
6CE8
6CEA
6CEC
6CED
6CEE
6CEF
7ZYU
8G43
8G44
8G45
|
1JCQ
1LD7
1LD8
1MZC
1S63
1SA4
1TN6
2F0Y
2H6F
2H6G
2H6H
2H6I
2IEJ
3E37
|
| GO Terms Enriched among Interactors |
|
|